Why the study?
The prevalence of T2DM has more than doubled in the past 20 years, and hypertriglyceridemia is a prevalent, modifiable potential risk factor whose dose-dependent effect on T2DM development needed investigation.
Does hypertriglyceridemia and its related indices increase the risk of developing type 2 diabetes mellitus in adult patients without diabetes at baseline?
Does hypertriglyceridemia and its related indices increase the risk of developing type 2 diabetes mellitus in adult patients without diabetes at baseline?
Answers are grounded in this paper and cite their sources.
Hypertriglyceridemia and related indices, particularly the hypertriglyceridemic waist phenotype, are significant, dose-dependent risk factors for the development of type 2 diabetes, highlighting the importance of lipid management and central obesity reduction in diabetes prevention.
Introduction: The prevalence of type 2 diabetes mellitus (T2DM) has more than doubled in the past 20 years. Most T2DM cases are preventable if risk factors are eliminated early. Hypertriglyceridemia (HTG) is also a potential but modifiable risk factor, and has a high prevalence as well. We aimed to investigate the dose-dependent effect of HTG on the development of T2DM. Methods: We carried out a systematic search in three databases (MEDLINE, Embase, and CENTRAL) on 9 November 2023. We investigated an adult population with different triglyceride levels (exposure). The outcome of interest was the development of T2DM. Pooled hazard ratio (HR), odds ratio (OR), and mean differences (MDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Risk of bias was assessed with the Quality In Prognosis Studies (QUIPS) tool. The protocol was registered in PROSPERO (CRD42023471288). Results: We identified 31,098 articles and included 101 in our meta-analysis. We found that people with HTG had more than a 1.5-fold higher risk (HR: 1.73 [1.31; 2.29]) of developing T2DM. Those who had their TG levels between 1.7 and 2.3 mmol/L had a 42% higher risk (HR: 1.42 [1.13; 1.79]), while those with TG levels above 2.3 mmol/L had an even higher risk for T2DM (HR: 1.82 [1.18; 2.87]) compared with patients with TG levels below 1.7 mmol/L. When investigating the hypertriglyceridemic waist phenotype, we found that only those with increased waist circumference had a higher risk in both sex groups among the different phenotype groups (female: HR: 2.86 [1.59; 5.14], male: HR: 3.31 [1.57; 7.27]). Conclusion: HTG is a dose-dependent risk factor for T2DM. Elevated waist circumference may have an even more important role in the development of T2DM than HTG. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42023471288.
No takes yet. Share an insight, caveat, or question.
Havelda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: